Muscular dystrophy (MD) refers to a group of more than 30 genetic diseases characterized by progressive weakness and degeneration of the skeletal muscles that control movement. Some forms of MD are seen in newborns, infants or children, while others have late-onset and may not appear until middle age or later. The disorders differ in terms of the distribution and extent of muscle weakness (some forms of MD also affect cardiac muscle), age of onset, rate of progression, and pattern of inheritance. The prognosis for people with MD varies according to the type and progression of the disorder. There is no specific treatment to stop or reverse any form of MD. Treatment is supportive and may include physical therapy, respiratory therapy, speech therapy, orthopedic appliances used for support, corrective orthopedic surgery, and medicationsincluding corticosteroids, anticonvulsants (seizure medications), immunosuppressants, and antibiotics. Some individuals may need assisted ventilation to treat respiratory muscle weaknessor a pacemaker for cardiac (heart)abnormalities. [ https://rarediseases.info.nih.gov/diseases/7922/muscular-dystrophy ]

This is just here as a test because I lose it

Term information

database cross reference
  • MedDRA:10028356 (Orphanet:98473)
  • NCIT:C84910 (MONDO:equivalentTo)
  • MESH:D009136 (Orphanet:98473)
  • GARD:0007922 (MONDO:equivalentTo)
  • ICD9:359.1 (DOID:9884)
  • UMLS:C0026850 (Orphanet:98473)
  • ICD10:G71.0 (Orphanet:98473)
  • COHD:4247802 (MONDO:equivalentTo)
  • DOID:9884 (MONDO:equivalentTo)
  • Orphanet:98473 (MONDO:equivalentTo)
  • SCTID:73297009 (MONDO:equivalentTo)
Subsets

gard_rare, ordo_group_of_disorders

closeMatch

http://identifiers.org/snomedct/193257004

http://identifiers.org/snomedct/193236007

http://identifiers.org/snomedct/267712004

http://identifiers.org/snomedct/44292004

http://identifiers.org/snomedct/155095006

http://identifiers.org/snomedct/193225000

definition

Muscular dystrophy (MD) refers to a group of more than 30 genetic diseases characterized by progressive weakness and degeneration of the skeletal muscles that control movement. Some forms of MD are seen in newborns, infants or children, while others have late-onset and may not appear until middle age or later. The disorders differ in terms of the distribution and extent of muscle weakness (some forms of MD also affect cardiac muscle), age of onset, rate of progression, and pattern of inheritance. The prognosis for people with MD varies according to the type and progression of the disorder. There is no specific treatment to stop or reverse any form of MD. Treatment is supportive and may include physical therapy, respiratory therapy, speech therapy, orthopedic appliances used for support, corrective orthopedic surgery, and medicationsincluding corticosteroids, anticonvulsants (seizure medications), immunosuppressants, and antibiotics. Some individuals may need assisted ventilation to treat respiratory muscle weaknessor a pacemaker for cardiac (heart)abnormalities.

exactMatch

http://www.orpha.net/ORDO/Orphanet_98473

http://identifiers.org/snomedct/73297009

http://identifiers.org/meddra/10028356

http://purl.obolibrary.org/obo/NCIT_C84910

http://identifiers.org/mesh/D009136

http://purl.obolibrary.org/obo/DOID_9884

http://linkedlifedata.com/resource/umls/id/C0026850

id

MONDO:0020121

seeAlso

https://rarediseases.info.nih.gov/diseases/7922/muscular-dystrophy